Spero Therapeutics (SPRO) announced that Esther Rajavelu will serve as its president and CEO, effective May 2 and will be nominated for election as a member of the board of directors at Spero’s annual meeting of stockholders. Since January, Rajavelu has been serving as Spero’s interim president and CEO, and has served as CFO, treasurer, and chief business officer since November 2023. She will continue to serve as the company’s CFO and treasurer.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRO:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue